HAE
Clinical trials for HAE explained in plain language.
Never miss a new study
Get alerted when new HAE trials appear
Sign up with your email to follow new studies for HAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for HAE patients: extension study tests long-term attack prevention
Disease control Recruiting nowThis study is for people with hereditary angioedema (HAE) who have already completed a prior phase 3 trial of ADX-324. It aims to see how safe and effective the drug is over a longer period, and whether it can reduce the number of swelling attacks. About 90 adults will receive ad…
Matched conditions: HAE
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New RNA drug aims to stop painful swelling attacks in rare genetic disease
Disease control Recruiting nowThis study tests an experimental drug called ADX-324 in 90 adults with hereditary angioedema (HAE) types 1 or 2. The drug uses a technology called siRNA to lower a protein involved in swelling attacks. Participants receive either the drug or a placebo to see if it safely reduces …
Matched conditions: HAE
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 08:22 UTC
-
New artery-blocking procedure aims to stop hemorrhoid bleeding without surgery
Symptom relief Recruiting nowThis study tests a procedure called hemorrhoidal artery embolization (HAE) for people with internal hemorrhoids who have not had success with other treatments or cannot have surgery. HAE blocks the blood supply to the hemorrhoid tissue to reduce symptoms, especially bleeding. Abo…
Matched conditions: HAE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated May 04, 2026 16:18 UTC